SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony@Pacific who wrote (3468)12/13/2000 5:25:19 PM
From: Mike M  Read Replies (1) of 5582
 
Tony, forget Zicam, for now. You must realize that GUMM is operating in company with huge companies who have already made small investments in GUMM. All of these investments have suggested more definitive relationships down the road. These companies can change GUMM's fortunes literally overnight.

I'm not questioning your courage, but I wonder what could make you want to jump on a tiny company like this, especially at this price. That low float is a double edged sword.

It isn't much of a stretch deducing that a company operating at just a little more than 10% of existing capacity, using a check from P&G to increase that capacity, has some fairly big plans. It can't be to sell more brain gum.

Somebody tried to push the stock down today and ended with nothing to show for it, save more exposure. It just doesn't make sense to me.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News